Tim McCarthy | LifeSci Advisors |
Sergio Traversa | CEO |
Cedric O'Gorman | Chief Medical Officer |
Maged Shenouda | CFO |
Rudy Li | Leerink Partner |
Andrea Tan | Goldman Sachs |
Greetings, and welcome to Relmada Therapeutics Inc.
Second Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
It's now my pleasure to introduce your host, Tim McCarthy, LifeSci Advisors. Please, Mr.